Alzamend Neuro, Inc.ALZNNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank44
3Y CAGR-24.8%
5Y CAGR-2.0%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
-24.8%/yr
vs +87.6%/yr prior
5Y CAGR
-2.0%/yr
Recent deceleration
Acceleration
-112.3pp
Decelerating
Percentile
P44
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $3.03M | -13.0% |
| 2024 | $3.48M | -53.1% |
| 2023 | $7.42M | +4.3% |
| 2022 | $7.12M | +95.5% |
| 2021 | $3.64M | +8.5% |
| 2020 | $3.35M | +156.3% |
| 2019 | $1.31M | +127.6% |
| 2018 | $575027.00 | -54.8% |
| 2017 | $1.27M | +1732.8% |
| 2016 | $69456.00 | - |